January 05, 2012
DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)

January 05, 2012
Durect Corp to Discuss POSIDUR Clinical Trial Results

November 07, 2011
DURECT Corporation to Participate in Upcoming Healthcare Conferences

November 03, 2011
DURECT Corporation Announces Third Quarter 2011 Financial Results and Update of Programs

October 26, 2011
DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call

September 10, 2011
DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR(R) (BESST)

September 06, 2011
DURECT Completes Enrollment in Pivotal U.S. Phase III Trial for POSIDUR® (BESST)

2010 Annual Report